The University of Chicago Header Logo

Connection

Jessica Donington to Carcinoma, Non-Small-Cell Lung

Back to Details
This is a "connection" page, showing publications Jessica Donington has written about Carcinoma, Non-Small-Cell Lung.
Jessica Donington
Connection Strength
13.393
Carcinoma, Non-Small-Cell Lung
  1. Current Management of Stage IIIA (N2) Non-Small-Cell Lung Cancer: Role of Perioperative Immunotherapy, and Tyrosine Kinase Inhibitors. Thorac Surg Clin. 2023 May; 33(2):189-196.
    View in: PubMed
    Score: 0.479
  2. Oncologic end points and implication of trial design in the era of immunotherapy for resectable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 06; 165(6):1949-1953.
    View in: PubMed
    Score: 0.469
  3. Lung resection surgery in Jehovah's Witness patients: a 20-year single-center experience. J Cardiothorac Surg. 2022 Oct 20; 17(1):272.
    View in: PubMed
    Score: 0.468
  4. Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon. Ann Thorac Surg. 2023 06; 115(6):1544-1555.
    View in: PubMed
    Score: 0.466
  5. Neoadjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer: Exciting New Horizon in Early-Stage Lung Cancer Care. Ann Surg Oncol. 2022 09; 29(9):5344-5346.
    View in: PubMed
    Score: 0.455
  6. The Increasing Role of Surgery in Comprehensive Treatment of Advanced Non-small Cell Lung Cancer with Targetable Mutations. Ann Surg Oncol. 2022 08; 29(8):4679-4680.
    View in: PubMed
    Score: 0.453
  7. Surgical Issues for Operable Early-Stage Non-Small-Cell Lung Cancer. J Clin Oncol. 2022 02 20; 40(6):530-538.
    View in: PubMed
    Score: 0.443
  8. Commentary: Why do we operate in metastatic lung cancer? J Thorac Cardiovasc Surg. 2022 03; 163(3):826-827.
    View in: PubMed
    Score: 0.423
  9. Resection following concurrent chemotherapy and high-dose radiation for stage IIIA non-small cell lung cancer. J Thorac Cardiovasc Surg. 2020 11; 160(5):1331-1345.e1.
    View in: PubMed
    Score: 0.396
  10. Commentary: Why does neoadjuvant therapy suddenly make sense for early stage non-small cell lung cancer? J Thorac Cardiovasc Surg. 2020 11; 160(5):1383-1384.
    View in: PubMed
    Score: 0.394
  11. Commentary: The need to RIOT (return to intended oncologic treatment) after lung cancer surgery. J Thorac Cardiovasc Surg. 2019 07; 158(1):287-288.
    View in: PubMed
    Score: 0.367
  12. The Role of Surgery in Management of Locally Advanced Non-Small Cell Lung Cancer. Curr Treat Options Oncol. 2019 03 14; 20(4):27.
    View in: PubMed
    Score: 0.364
  13. Early-Stage NSCLC: Advances in Thoracic Oncology 2018. J Thorac Oncol. 2019 06; 14(6):968-978.
    View in: PubMed
    Score: 0.364
  14. Commentary: Keeping surgery relevant in oligometastatic non-small cell lung cancer. J Thorac Cardiovasc Surg. 2019 04; 157(4):1629-1630.
    View in: PubMed
    Score: 0.356
  15. Thoracotomy for Stage I Lung Cancer Resections: A Procedure Past Its Time. J Clin Oncol. 2018 08 10; 36(23):2361-2362.
    View in: PubMed
    Score: 0.347
  16. Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017. J Thorac Oncol. 2018 06; 13(6):767-778.
    View in: PubMed
    Score: 0.342
  17. Salvage Resections for Stage III Non-small Cell Lung Cancer: A Curious Area of Investigation. Semin Thorac Cardiovasc Surg. 2017; 29(2):242-243.
    View in: PubMed
    Score: 0.318
  18. Surgical Treatment of Early l Stage Lung Cancer: What has Changed and What will Change in the Future. Semin Respir Crit Care Med. 2016 10; 37(5):708-715.
    View in: PubMed
    Score: 0.308
  19. Sublobar Resection: Ongoing Controversy for Treatment for Stage I Non-Small Cell Lung Cancer. Thorac Surg Clin. 2016 Aug; 26(3):251-9.
    View in: PubMed
    Score: 0.304
  20. Survival After Sublobar Resection Versus Lobectomy for Clinical Stage IA Lung Cancer: Analysis From the National Cancer Database. J Thorac Oncol. 2015 Nov; 10(11):1513-4.
    View in: PubMed
    Score: 0.288
  21. Radiofrequency ablation in high-risk stage I non-small cell lung cancer. Cancer. 2015 Oct 01; 121(19):3393-4.
    View in: PubMed
    Score: 0.281
  22. Surgical resection of non-small cell lung cancer with N2 disease. Thorac Surg Clin. 2014 Nov; 24(4):449-56.
    View in: PubMed
    Score: 0.267
  23. Managing lung cancer in high-risk patients: what to consider. Expert Rev Respir Med. 2014 Aug; 8(4):443-52.
    View in: PubMed
    Score: 0.262
  24. Invited commentary. Ann Thorac Surg. 2013 Dec; 96(6):1951.
    View in: PubMed
    Score: 0.253
  25. Response. Chest. 2013 May; 143(5):1518-1519.
    View in: PubMed
    Score: 0.243
  26. Surgical approach to locally advanced non-small cell lung cancer. Cancer J. 2013 May-Jun; 19(3):217-21.
    View in: PubMed
    Score: 0.243
  27. Invited commentary. Ann Thorac Surg. 2013 Feb; 95(2):418-9.
    View in: PubMed
    Score: 0.238
  28. Current readings: sublobar resection for non-small-cell lung cancer. Semin Thorac Cardiovasc Surg. 2013; 25(1):22-9.
    View in: PubMed
    Score: 0.237
  29. American College of Chest Physicians and Society of Thoracic Surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012 Dec; 142(6):1620-1635.
    View in: PubMed
    Score: 0.236
  30. Point: are limited resections appropriate in non-small cell lung cancer? Yes. Chest. 2012 Mar; 141(3):588-590.
    View in: PubMed
    Score: 0.224
  31. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark. 2012; 12(4):177-84.
    View in: PubMed
    Score: 0.221
  32. Management of early stage non-small cell lung cancer in high-risk patients. Thorac Surg Clin. 2012 Feb; 22(1):55-65, vi.
    View in: PubMed
    Score: 0.218
  33. Novel therapies for non-small cell lung cancer. J Thorac Imaging. 2011 May; 26(2):175-85.
    View in: PubMed
    Score: 0.211
  34. Sex and gender differences in non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2011; 23(2):137-45.
    View in: PubMed
    Score: 0.206
  35. Functional heterogeneity of osteopontin isoforms in non-small cell lung cancer. J Thorac Oncol. 2010 Oct; 5(10):1516-23.
    View in: PubMed
    Score: 0.203
  36. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):936-41.
    View in: PubMed
    Score: 0.193
  37. Lung cancer osteopontin isoforms exhibit angiogenic functional heterogeneity. J Thorac Cardiovasc Surg. 2010 Jun; 139(6):1587-93.
    View in: PubMed
    Score: 0.190
  38. The role of surgery in the treatment of stage III non-small-cell lung cancer. Curr Oncol Rep. 2007 Jul; 9(4):247-54.
    View in: PubMed
    Score: 0.162
  39. Management of locally advanced non small cell lung cancer from a surgical perspective. Curr Treat Options Oncol. 2007 Feb; 8(1):1-14.
    View in: PubMed
    Score: 0.157
  40. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006 Oct; 1(8):802-9.
    View in: PubMed
    Score: 0.154
  41. Treatment Decisions for Resectable Non-Small-Cell Lung Cancer: Balancing Less With More? Am Soc Clin Oncol Educ Book. 2023 May; 43:e389950.
    View in: PubMed
    Score: 0.121
  42. STK11 Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer. JCO Precis Oncol. 2023 01; 7:e2200273.
    View in: PubMed
    Score: 0.119
  43. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.109
  44. American Radium Society Appropriate Use Criteria for Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2022 02 01; 112(2):361-375.
    View in: PubMed
    Score: 0.109
  45. Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic. J Thorac Oncol. 2020 07; 15(7):1137-1146.
    View in: PubMed
    Score: 0.098
  46. The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for Residual Tumor Descriptors for Non-Small Cell Lung Cancer. J Thorac Oncol. 2020 03; 15(3):344-359.
    View in: PubMed
    Score: 0.095
  47. The value of collaboration between thoracic surgeons and radiation oncologists while awaiting evidence in operable stage i non-small cell lung cancer. J Thorac Cardiovasc Surg. 2018 Jan; 155(1):429-431.
    View in: PubMed
    Score: 0.084
  48. Randomized Phase II Study of Preoperative Chemoradiotherapy ± Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-Small Cell Lung Cancer: NRG Oncology RTOG 0839. J Thorac Oncol. 2017 09; 12(9):1413-1420.
    View in: PubMed
    Score: 0.081
  49. Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive Summary of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol. 2017 Sep - Oct; 7(5):295-301.
    View in: PubMed
    Score: 0.081
  50. Local Therapy for Limited Metastatic Non-Small Cell Lung Cancer: What Are the Options and Is There a Benefit? Am Soc Clin Oncol Educ Book. 2016; 35:e460-7.
    View in: PubMed
    Score: 0.073
  51. Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep; 12(5):280-5.
    View in: PubMed
    Score: 0.054
  52. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6.
    View in: PubMed
    Score: 0.053
  53. Complications of ablative therapies in lung cancer. Clin Lung Cancer. 2008 Mar; 9(2):122-6.
    View in: PubMed
    Score: 0.042
  54. A multidisciplinary approach to management in a patient with bilateral superior sulcus non-small-cell lung carcinoma. Clin Lung Cancer. 2006 Sep; 8(2):146-8.
    View in: PubMed
    Score: 0.038
  55. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.